arrow
N

Noboru Asada

okayama university graduate school of medicine dentistry and pharmaceutical sciences
H指数:24
被引数:3,525

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation

供者年龄作为异基因造血干细胞移植中供者安全性和受者生存的双风险因素

2026-08-210
PRE
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient age

女性供者至男性受者的异基因造血细胞移植对生存结局的影响因受者年龄而异

2026-05-270
PRE
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group

异基因造血细胞移植后菌血症与巨细胞病毒感染的双向关联:JSTCT 移植并发症工作组

2026-05-130
PRE
Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapse/refractory FLT3-mutated acute myeloid leukemia

使用吉列替尼维持治疗可抑制FLT3突变型复发性/难治性急性髓系白血病移植后复发

2026-04-120
OAAI
Trends in survival outcomes after allogeneic transplantation for MDS and MDS/MPN in a real-world experience: A 25-year nationwide study

异基因移植后MDS和MDS/MPN生存结局的趋势:一项25年的全国性真实世界研究

2026-04-050
PRE
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

总身体照射剂量在急性髓系白血病异基因造血细胞移植减低强度预处理中的影响

2026-03-020
PRE
Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantation

异基因造血干细胞移植后免疫抑制治疗终止的显著临床影响

2026-03-010
PRE
Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation

造血干细胞移植后闭塞性细支气管炎中巨噬细胞向肌成纤维细胞转化的空间转录组学分析

2025-12-200
PRE
Letermovir prophylaxis and risk of bacterial or fungal infection after allogeneic hematopoietic cell transplantation

Letermovir预防与异基因造血细胞移植后细菌或真菌感染的风险

2025-12-010
PRE
The Limited Impact of Pre-existing Rheumatologic Diseases on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Propensity–Score Matched Analysis

自身免疫性疾病对异基因造血干细胞移植预后的有限影响:一项全国性倾向性评分匹配分析

2025-11-050
PRE
Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures

移植物抗宿主病对慢性髓单核细胞白血病患者移植后结局的不同影响:按移植方案分类

2025-11-010
PRE
Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective Study

血小板恢复及其对异基因造血干细胞移植后结局的影响:一项日本全国性回顾性研究

2025-10-290
OAAI
Late-Onset Invasive Aspergillosis With Pituitary Involvement and Dysfunction Following CD19 Chimeric Antigen Receptor T-Cell Therapy

迟发性侵袭性曲霉菌病伴垂体受累及功能障碍,发生于CD19嵌合抗原受体T细胞疗法之后

2025-10-010
OAAI
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT

甲氨蝶呤给药方案对HLA匹配异基因造血干细胞移植中GVHD预防的临床结局的影响

2025-10-010
OAAI
Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study

非严重性再生障碍性贫血且不需输血患者中环孢素单药治疗的有效性:一项多中心II期研究的结果

2025-09-080
OAAI
Loss-Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia

易丢失的HLA I类等位基因揭示了获得性再生障碍性贫血早期造血细胞移植的结局

2025-09-050
PRE
Risk Stratification Using DIPSS and Splenomegaly in Myelofibrosis Treated with Pre-Transplant JAK inhibitors

使用DIPSS和脾肿大对接受移植前JAK抑制剂治疗的原发性骨髓纤维化进行风险分层

2025-09-030
PRE
Comparison of survival outcomes between chimeric antigen receptor T-cell therapy recipients with and without central nervous system involvement

比较有无中枢神经系统受累的嵌合抗原受体T细胞疗法受试者的生存结局

2025-08-050
PRE